Evidence map›Paper›PMID 20739936›Full record

ArticleNature2010

Phosphorylation of the CPC by Cdk1 promotes chromosome bi-orientation.

Tatsuya Tsukahara, Yuji Tanno, Yoshinori Watanabe

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 245 citations in OpenAlex.

  1. Review
  2. Article
  3. Countervailing effects of cyclin isoforms A and B during mitosis.bioRxiv : the preprint server for biology · 2026
    Article
  4. Oocyte Kinetochores at the Nexus of Meiotic Drive and Segregation Fidelity.Advances in experimental medicine and biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tatsuya TsukaharaLaboratory of Chromosome Dynamics, Institute of Molecular and Cellular Biosciences, University of Tokyo, Yayoi, Tokyo 113-0032, Japan.
Yuji Tanno
Yoshinori Watanabe
The University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Successful partition of replicated genomes at cell division requires chromosome attachment to opposite poles of mitotic spindle (bi-orientation). Any defects in this regulation bring about chromosomal instability, which may accelerate tumour progression in humans. To achieve chromosome bi-orientation at prometaphase, the chromosomal passenger complex (CPC), composed of catalytic kinase Aurora B and regulatory components (INCENP, Survivin and Borealin), must be localized to centromeres to phosphorylate kinetochore substrates. Although the CPC dynamically changes the subcellular localization, the regulation of centromere targeting is largely unknown. Here we isolated a fission yeast cyclin B mutant defective specifically in chromosome bi-orientation. Accordingly, we identified Cdk1 (also known as Cdc2)-cyclin-B-dependent phosphorylation of Survivin. Preventing Survivin phosphorylation impairs centromere CPC targeting as well as chromosome bi-orientation, whereas phosphomimetic Survivin suppresses the bi-orientation defect in the cyclin B mutant. Survivin phosphorylation promotes direct binding with shugoshin, which we now define as a conserved centromeric adaptor of the CPC. In human cells, the phosphorylation of Borealin has a comparable role. Thus, our study resolves the conserved mechanisms of CPC targeting to centromeres, highlighting a key role of Cdk1-cyclin B in chromosome bi-orientation.

Indexed as

Amino Acid SequenceAnimalsAurora Kinase BAurora KinasesCarrier ProteinsCDC2 Protein KinaseCell Cycle ProteinsCell LineCentromereChromosomal Proteins, Non-HistoneChromosomes, FungalChromosomes, HumanCyclin BHumansInhibitor of Apoptosis ProteinsMicrotubule-Associated Proteinsark1 protein, S pombeAURKB protein, humanAurora Kinase BAurora KinasesBir1 protein, S pombeBIRC5 protein, humanCarrier ProteinsCdc13 protein, S pombeCDC2 Protein Kinasecdc2 protein, S pombeCDCA8 protein, humanCell Cycle ProteinsChromosomal Proteins, Non-HistoneCyclin BINCENP protein, humanInhibitor of Apoptosis ProteinsMicrotubule-Associated ProteinsMultiprotein ComplexesNbl1 protein, S pombeProtein Serine-Threonine KinasesSchizosaccharomyces pombe ProteinsSGO1 protein, humanSGO2 protein, humanSgo2 protein, S pombeSurvivin

Identifiers

PMID20739936
OpenAlexW1987118575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.